img

Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 282 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Report 2024

The global Polyarticular Juvenile Idiopathic Arthritis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polyarticular Juvenile Idiopathic Arthritis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Etanercept Biosimilar
Tocilizumab Biosimilar
Sarilumab
Adalimumab Biosimilar
Others


Segment by Application


Hospital
Clinic
Others

The Polyarticular Juvenile Idiopathic Arthritis Drug market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Polyarticular Juvenile Idiopathic Arthritis Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Biocon Ltd
Coherus BioSciences Inc
Livzon Pharmaceutical Group Inc
Momenta Pharmaceuticals Inc
Mycenax Biotech Inc
Oncobiologics Inc
Oncodesign SA
Panacea Biotec Ltd
Regeneron Pharmaceuticals Inc
Sandoz International GmbH
UCB SA

Table of Content

1 Polyarticular Juvenile Idiopathic Arthritis Drug Market Overview
1.1 Polyarticular Juvenile Idiopathic Arthritis Drug Product Scope
1.2 Polyarticular Juvenile Idiopathic Arthritis Drug Segment by Type
1.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Etanercept Biosimilar
1.2.3 Tocilizumab Biosimilar
1.2.4 Sarilumab
1.2.5 Adalimumab Biosimilar
1.2.6 Others
1.3 Polyarticular Juvenile Idiopathic Arthritis Drug Segment by Application
1.3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Polyarticular Juvenile Idiopathic Arthritis Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price Trends (2016-2027)

2 Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Forecasts by Region
2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Region (2016-2021)
2.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Projections (2016-2027)
2.4.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Projections (2016-2027)
2.4.3 China Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Projections (2016-2027)
2.4.4 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Projections (2016-2027)
2.4.6 India Polyarticular Juvenile Idiopathic Arthritis Drug Estimates and Projections (2016-2027)

3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Competition Landscape by Players
3.1 Global Top Polyarticular Juvenile Idiopathic Arthritis Drug Players by Sales (2016-2021)
3.2 Global Top Polyarticular Juvenile Idiopathic Arthritis Drug Players by Revenue (2016-2021)
3.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polyarticular Juvenile Idiopathic Arthritis Drug as of 2020)
3.4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Average Price by Company (2016-2021)
3.5 Manufacturers Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size by Type
4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price by Type (2016-2021)
4.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price Forecast by Type (2022-2027)

5 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size by Application
5.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price by Application (2016-2021)
5.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price Forecast by Application (2022-2027)

6 North America Polyarticular Juvenile Idiopathic Arthritis Drug Market Facts & Figures
6.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company
6.1.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company (2016-2021)
6.1.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021)
6.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type
6.2.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2022-2027)
6.3 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application
6.3.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application (2022-2027)

7 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Market Facts & Figures
7.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company
7.1.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company (2016-2021)
7.1.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021)
7.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type
7.2.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Polyarticular Juvenile Idiopathic Arthritis Drug Market Facts & Figures
8.1 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company
8.1.1 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company (2016-2021)
8.1.2 China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021)
8.2 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type
8.2.1 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2022-2027)
8.3 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application
8.3.1 China 150 Sales Breakdown by Application (2016-2021)
8.3.2 China 150 Sales Breakdown by Application (2022-2027)

9 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Market Facts & Figures
9.1 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company
9.1.1 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company (2016-2021)
9.1.2 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021)
9.2 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type
9.2.1 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Market Facts & Figures
10.1 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company
10.1.1 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type
10.2.1 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Polyarticular Juvenile Idiopathic Arthritis Drug Market Facts & Figures
11.1 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company
11.1.1 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Company (2016-2021)
11.1.2 India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021)
11.2 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type
11.2.1 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Type (2022-2027)
11.3 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application
11.3.1 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Polyarticular Juvenile Idiopathic Arthritis Drug Business
12.1 Biocon Ltd
12.1.1 Biocon Ltd Corporation Information
12.1.2 Biocon Ltd Business Overview
12.1.3 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.1.5 Biocon Ltd Recent Development
12.2 Coherus BioSciences Inc
12.2.1 Coherus BioSciences Inc Corporation Information
12.2.2 Coherus BioSciences Inc Business Overview
12.2.3 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.2.5 Coherus BioSciences Inc Recent Development
12.3 Livzon Pharmaceutical Group Inc
12.3.1 Livzon Pharmaceutical Group Inc Corporation Information
12.3.2 Livzon Pharmaceutical Group Inc Business Overview
12.3.3 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.3.5 Livzon Pharmaceutical Group Inc Recent Development
12.4 Momenta Pharmaceuticals Inc
12.4.1 Momenta Pharmaceuticals Inc Corporation Information
12.4.2 Momenta Pharmaceuticals Inc Business Overview
12.4.3 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.4.5 Momenta Pharmaceuticals Inc Recent Development
12.5 Mycenax Biotech Inc
12.5.1 Mycenax Biotech Inc Corporation Information
12.5.2 Mycenax Biotech Inc Business Overview
12.5.3 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.5.5 Mycenax Biotech Inc Recent Development
12.6 Oncobiologics Inc
12.6.1 Oncobiologics Inc Corporation Information
12.6.2 Oncobiologics Inc Business Overview
12.6.3 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.6.5 Oncobiologics Inc Recent Development
12.7 Oncodesign SA
12.7.1 Oncodesign SA Corporation Information
12.7.2 Oncodesign SA Business Overview
12.7.3 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.7.5 Oncodesign SA Recent Development
12.8 Panacea Biotec Ltd
12.8.1 Panacea Biotec Ltd Corporation Information
12.8.2 Panacea Biotec Ltd Business Overview
12.8.3 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.8.5 Panacea Biotec Ltd Recent Development
12.9 Regeneron Pharmaceuticals Inc
12.9.1 Regeneron Pharmaceuticals Inc Corporation Information
12.9.2 Regeneron Pharmaceuticals Inc Business Overview
12.9.3 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.9.5 Regeneron Pharmaceuticals Inc Recent Development
12.10 Sandoz International GmbH
12.10.1 Sandoz International GmbH Corporation Information
12.10.2 Sandoz International GmbH Business Overview
12.10.3 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.10.5 Sandoz International GmbH Recent Development
12.11 UCB SA
12.11.1 UCB SA Corporation Information
12.11.2 UCB SA Business Overview
12.11.3 UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Products Offered
12.11.5 UCB SA Recent Development

13 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Cost Analysis
13.1 Polyarticular Juvenile Idiopathic Arthritis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
13.4 Polyarticular Juvenile Idiopathic Arthritis Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Polyarticular Juvenile Idiopathic Arthritis Drug Distributors List
14.3 Polyarticular Juvenile Idiopathic Arthritis Drug Customers

15 Market Dynamics
15.1 Polyarticular Juvenile Idiopathic Arthritis Drug Market Trends
15.2 Polyarticular Juvenile Idiopathic Arthritis Drug Drivers
15.3 Polyarticular Juvenile Idiopathic Arthritis Drug Market Challenges
15.4 Polyarticular Juvenile Idiopathic Arthritis Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Region (2016-2021)
Table 6. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Region (2016-2021)
Table 8. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Company (2016-2021)
Table 14. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Company (2016-2021)
Table 16. Global Polyarticular Juvenile Idiopathic Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polyarticular Juvenile Idiopathic Arthritis Drug as of 2020)
Table 17. Global Polyarticular Juvenile Idiopathic Arthritis Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Polyarticular Juvenile Idiopathic Arthritis Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Type (2016-2021)
Table 23. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Polyarticular Juvenile Idiopathic Arthritis Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Type (2022-2027)
Table 26. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Type (2022-2027)
Table 28. Global Polyarticular Juvenile Idiopathic Arthritis Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Application (2016-2021)
Table 31. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Polyarticular Juvenile Idiopathic Arthritis Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Application (2022-2027)
Table 35. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Application (2022-2027)
Table 37. Global Polyarticular Juvenile Idiopathic Arthritis Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Company (2016-2021)
Table 40. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
Table 44. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2022-2027)
Table 46. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
Table 48. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2022-2027)
Table 62. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Company (2016-2021)
Table 64. China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Company (2016-2021)
Table 66. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
Table 68. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2022-2027)
Table 70. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
Table 72. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2022-2027)
Table 98. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Company (2016-2021)
Table 100. India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Company (2016-2021)
Table 102. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2016-2021)
Table 104. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type (2022-2027)
Table 106. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2016-2021)
Table 108. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2022-2027)
Table 110. Biocon Ltd Corporation Information
Table 111. Biocon Ltd Description and Business Overview
Table 112. Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 114. Biocon Ltd Recent Development
Table 115. Coherus BioSciences Inc Corporation Information
Table 116. Coherus BioSciences Inc Description and Business Overview
Table 117. Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 119. Coherus BioSciences Inc Recent Development
Table 120. Livzon Pharmaceutical Group Inc Corporation Information
Table 121. Livzon Pharmaceutical Group Inc Description and Business Overview
Table 122. Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 124. Livzon Pharmaceutical Group Inc Recent Development
Table 125. Momenta Pharmaceuticals Inc Corporation Information
Table 126. Momenta Pharmaceuticals Inc Description and Business Overview
Table 127. Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 129. Momenta Pharmaceuticals Inc Recent Development
Table 130. Mycenax Biotech Inc Corporation Information
Table 131. Mycenax Biotech Inc Description and Business Overview
Table 132. Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 134. Mycenax Biotech Inc Recent Development
Table 135. Oncobiologics Inc Corporation Information
Table 136. Oncobiologics Inc Description and Business Overview
Table 137. Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 139. Oncobiologics Inc Recent Development
Table 140. Oncodesign SA Corporation Information
Table 141. Oncodesign SA Description and Business Overview
Table 142. Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 144. Oncodesign SA Recent Development
Table 145. Panacea Biotec Ltd Corporation Information
Table 146. Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Panacea Biotec Ltd Description and Business Overview
Table 148. Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 149. Panacea Biotec Ltd Recent Development
Table 150. Regeneron Pharmaceuticals Inc Corporation Information
Table 151. Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 153. Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 154. Regeneron Pharmaceuticals Inc Recent Development
Table 155. Sandoz International GmbH Corporation Information
Table 156. Sandoz International GmbH Description and Business Overview
Table 157. Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 159. Sandoz International GmbH Recent Development
Table 160. UCB SA Corporation Information
Table 161. UCB SA Description and Business Overview
Table 162. UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Product
Table 164. UCB SA Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Polyarticular Juvenile Idiopathic Arthritis Drug Distributors List
Table 168. Polyarticular Juvenile Idiopathic Arthritis Drug Customers List
Table 169. Polyarticular Juvenile Idiopathic Arthritis Drug Market Trends
Table 170. Polyarticular Juvenile Idiopathic Arthritis Drug Market Drivers
Table 171. Polyarticular Juvenile Idiopathic Arthritis Drug Market Challenges
Table 172. Polyarticular Juvenile Idiopathic Arthritis Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Polyarticular Juvenile Idiopathic Arthritis Drug Product Picture
Figure 2. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Etanercept Biosimilar Product Picture
Figure 4. Tocilizumab Biosimilar Product Picture
Figure 5. Sarilumab Product Picture
Figure 6. Adalimumab Biosimilar Product Picture
Figure 7. Others Product Picture
Figure 8. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Others Examples
Figure 12. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Polyarticular Juvenile Idiopathic Arthritis Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Polyarticular Juvenile Idiopathic Arthritis Drug Players Market Share by Revenue in Polyarticular Juvenile Idiopathic Arthritis Drug: 2016 & 2020
Figure 31. Polyarticular Juvenile Idiopathic Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Type (2016-2021)
Figure 33. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Application (2016-2021)
Figure 35. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2020
Figure 37. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2020
Figure 38. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2020
Figure 39. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2020
Figure 40. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2020
Figure 41. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2020
Figure 42. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2020
Figure 43. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2020
Figure 46. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Type in 2020
Figure 47. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Polyarticular Juvenile Idiopathic Arthritis Drug
Figure 50. Manufacturing Process Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
Figure 51. Polyarticular Juvenile Idiopathic Arthritis Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed